Your Messages Inbox
Your Article Summary
See Latest ArticlesU.S. FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine
Sanofi-aventis, 09/16/09
Sanofi Pasteur, the vaccines division of the sanofi–aventis Group, announced that the U.S. Food and Drug Administration has approved the company's supplemental biologics license application for licensure of its Influenza A 2009 Monovalent Vaccine.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor